Vanguard Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-117,568
Closed -$85.8K – 4137
2026
Q1
$85.8K Buy
+117,568
New +$535K ﹤0.01% 3875

Other funds holding RVPH

Vanguard Capital Management's RVPH Position: Q2 2026 in Review

Vanguard Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 117,568 shares — an estimated $85.8K sold.

Vanguard Capital Management first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $85.8K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Vanguard Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 117,568 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $85.8K.
  • Vanguard Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
  • Vanguard Capital Management's REVIVA PHARMA HLDGS INC position peaked at $85.8K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.